[1]
Muhammad Azhar Sherkheli et al. 2026. COMPARING VONOPRAZAN TO HIGH-DOSE PROTON PUMP INHIBITORS FOR REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE. Insights – Journal of Health and Rehabilitation. 4, 3 (Mar. 2026), 1–7. DOI:https://doi.org/10.71000/dq29xg42.